One is that even in early-stage PD patients there has been a substantial loss of DAergic neurons and the processes driving the disease forward have changed to ones (e.g., inflammation) that will not be responsive to Cav1 channel inhibition. This evidence concerns the gene CAV1 and Parkinson disease.